基于Citation Topic和CiteSpace的长三角地区研究热点的可视化分析
Visual Analysis of Research Hotspots in Yangtze River Delta Based on Citation Topic and CiteSpace
DOI: 10.12677/SA.2023.125148, PDF,    科研立项经费支持
作者: 蒋海灵:浙江理工大学图书馆,浙江 杭州
关键词: 引文主题CiteSpace科学知识图谱研究热点长三角地区Citation Topic CiteSpace Scientific Knowledge Map Research Hotspots Yangtze River Delta
摘要: 【目的/意义】对长三角地区的研究热点进行可视化分析,助力区域创新研究。【方法/过程】以Web of Science核心合集数据库中收录的近5年(2018~2022年)长三角地区的文献为数据源,首先,借助InCites数据库的Citation Topic功能,对微观主题的发文量、总被引频次、高被引论文和学科规范化的引文影响力等指标进行对比分析;其次,以热门微观主题冠状病毒为例,采用CiteSpace软件对该微观主题文献进行机构合作、关键词共现和关键词聚类的科学知识图谱分析。【结果/结论】超级电容器、氧还原反应、光催化作用和冠状病毒是近5年长三角地区的热门研究领域;新型冠状肺炎疫情下人群的心理健康、新型冠状肺炎疫情传播模拟和预测模型、新型冠状病毒致病机理、单克隆抗体药物的研发、临床特征、药物筛选和疫苗研发等是冠状病毒研究主题的研究热点。【创新/局限】提供了一种结合Citation Topic和CiteSpace工具分析和挖掘区域研究主题与热点的新路径。
Abstract: [Purpose/significance] Visual analysis of research hotspots in the Yangtze River Delta region will support regional innovation research. [Method/process] Taking journal articles published in Yang-tze River Delta retrieved in Web of Science Core Collection in the recent 5 years (2018-2022) as the data source, first, based on the Citation Topics of InCites, a comparative analysis of indicators of mi-cro-topics, such as the number of papers, total cited times, highly cited papers and the category normalized citation impact, etc. is conducted; second, taking the micro-topic of coronavirus as an example, visual analysis of co-institution, keyword co-occurrence and clustering is made by CiteSpace knowledge mapping. [Result/conclusion] Supercapacitors, oxygen reduction reactions, photocatalysis, and coronavirus are the hot research topics in the Yangtze River Delta in the recent 5 year. Effect of COVID-19 on mental health of individuals, spread simulation and prediction models, pathogenesis, monoclonal antibody, clinical characteristics, drug screening and vaccine develop-ment of COVID-19, etc. are the hot research topics of the micro-topic of coronavirus. [Innova-tion/limitation] This paper provides a new path to analyze and mine regional research topics and hotspots by combining Citation Topic and CiteSpace tools.
文章引用:蒋海灵. 基于Citation Topic和CiteSpace的长三角地区研究热点的可视化分析[J]. 统计学与应用, 2023, 12(5): 1440-1450. https://doi.org/10.12677/SA.2023.125148

参考文献

[1] 贾永飞, 王振宇, 张欣, 等. 科技创新政策对区域创新能力的影响机理研究——基于fsQCA方法的组态分析[J]. 山东财经大学学报, 2023, 35(2): 87-96+121.
[2] Introducing Citation Topics in InCites.
https://clarivate.com/blog/introducing-citation-topics/
[3] 王燕, 姚蔚, 杜敏, 等. 利用InCites新功能Citation Topics助力学术期刊编辑制定选题策划方案——以园艺学科研究领域为例[J]. 中国科技期刊研究, 2021, 32(6): 777-785.
[4] 田沛霖, 赵蓉英, 常茹茹, 等. 信息计量学研究的知识结构与发展态势[J]. 情报科学, 2022, 40(7): 186-193.
[5] 刘迪, 张会来. 我国高校网络舆情的研究热点和前沿探析[J]. 情报科学, 2022, 40(11): 176-185.
[6] 陈晓玲, 刘东亮. 基于科学知识图谱的东北三省区域研究热点分析[J]. 情报学报, 2018, 37(12): 1224-1231.
[7] 张立, 尹萍. 我国图情领域近十年国际发文研究热点和前沿剖析[J]. 情报科学, 2020, 38(5): 80-87.
[8] Lai, J.B., Ma, S.M., Wang, Y., et al. (2020) Factors Associated With Mental Health Outcomes among Health Care Workers Exposed to Coronavirus Disease 2019. Jama Network Open, 3, e203976. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, C.Y., Pan, R.Y., Wan, X.Y., et al. (2020) Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epi-demic among the General Population in China. International Journal of Environmental Research and Public Health, 17, 1729-1753. [Google Scholar] [CrossRef] [PubMed]
[10] 裴韬, 王席, 宋辞, 等. COVID-19疫情时空分析与建模研究进展[J]. 地球信息科学学报, 2021, 23(2): 188-210.
[11] Zhao, S., Lin, Q.Y., Ran, J.J., et al. (2020) Preliminary Estimation of the Basic Reproduction Number of Novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A Data-Driven Analysis in the Early Phase of the Outbreak. International Journal of Infectious Diseases, 92, 214-217. [Google Scholar] [CrossRef] [PubMed]
[12] Yeoh, E.K., Chong, K.C., Chiew, C.J., et al. (2021) Assessing the Impact of Non-Pharmaceutical Interventions on the Transmissibility and Severity of COVID-19 during the First Five Months in the Western Pacific Region. One Health, 12, Article ID: 100213. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, H.W., Wang, Z.Z., Dong, Y.Q., et al. (2020) Phase-Adjusted Estimation of the Number of Coronavirus Disease 2019 cases in Wuhan, China. Cell Discovery, 6, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
[14] Yao, H.P., Song, Y.T., Chen, Y., et al. (2020) Molecular Architecture of the SARS-CoV-2 Virus. Cell, 183, 730-738. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, Q.H., Zhang, Y.F., Wu, L.L., et al. (2020) Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell, 181, 894-904. [Google Scholar] [CrossRef] [PubMed]
[16] Chi, X.Y., Yan, R.H., Zhang, J., et al. (2020) A Neutralizing Human An-tibody Binds to the N-Terminal Domain of the Spike Protein of SARS-CoV-2. Science, 369, 650-655. [Google Scholar] [CrossRef] [PubMed]
[17] Zhang, C., Wu, Z., Li, J.W., et al. (2020) Cytokine Release Syndrome in Se-vere COVID-19: Interleukin-6 Receptor Antagonist Tocilizumab May Be the Key to Reduce Mortality. International Journal of Antimicrobial Agents, 55, Article ID: 105954. [Google Scholar] [CrossRef] [PubMed]
[18] Guan, W., Ni, Z., Hu, Y., et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382, 1708-1720. [Google Scholar] [CrossRef
[19] Chen, N.S., Zhou, M., Dong, X., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet, 395, 507-513. [Google Scholar] [CrossRef
[20] Zhang, D.H., Wu, K.L., Zhang, X., et al. (2020) In silico Screening of Chinese Herbal Medicines with the Potential to Directly Inhibit 2019 Novel Coronavirus. Journal of Integrative Medicine-Jim, 18, 152-158. [Google Scholar] [CrossRef] [PubMed]
[21] Jin, Z.M., Du, X.Y., Xu, Y.C., et al. (2020) Structure of M-Pro from SARS-CoV-2 and Discovery of Its Inhibitors. Nature, 582, 289-293. [Google Scholar] [CrossRef] [PubMed]
[22] Zhu, F.C., Li, Y.H., Guan, X.H., et al. (2020) Safety, Tolerability, and Immunogenicity of a Recombinant Adenovirus Type-5 Vectored COVID-19 Vaccine: A Dose-Escalation, Open-Label, Non-Randomised, First-in-Human Trial. Lancet, 395, 1845-1854. [Google Scholar] [CrossRef
[23] Yang, J., Wang, W., Chen, Z., et al. (2020) A Vaccine Targeting the RBD of the S Protein of SARS-CoV-2 Induces Protective Immunity. Nature, 586, 572-577. [Google Scholar] [CrossRef] [PubMed]